EichorEICHOR
Study identifier: NCT05794204 Synced from ClinicalTrials.gov · August 02, 2026
● Completed

RMP-A03 Ocular Suspension in Patients With Pterygium

Condition: Pterygium  ·  Sponsor: Suzhou Raymon Pharmaceuticals Company, Ltd.

PhasePhase 2
Planned participants77
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this clinical trial is to test the safety and efficacy of an ocular medication on the treatment of pterygium.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (6)

Global Research ManagementGlendale, California, United States
United Medical Research InstituteInglewood, California, United States
Eye Research Foundation IncNewport Beach, California, United States
Oceane7 Medical & Research Center Inc.Miami, Florida, United States
Toyos ClinicNashville, Tennessee, United States
Keystone ResearchAustin, Texas, United States

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →